Search Results for:

Sort by: Relevance Date
76 - 90 of 146 Results

Are adequate networks adequate enough?

Current regulatory trends are generally focused on increasing enforcement of standards grounded in earlier and increasingly outdated business models.
Healthcare & Life Sciences Institute Mon, 10 Oct 2016 00:00:00 GMT

What Works: The trillion dollar quest

Healthcare organizations are able to unlock up to 15 percent in productivity gains. But how can others replicate this success?
Healthcare & Life Sciences Institute Wed, 02 Nov 2016 00:00:00 GMT

Intelligent Augmentation: Life sciences companies are a natural fit for digital labor, from robotics to cognitive

See how naturally advanced automation can be used in the life sciences back office, regulatory compliance, clinical trial process, pharmacovigilance efforts, and more strategic applications of data and analytics.
Healthcare & Life Sciences Institute Mon, 03 Oct 2016 00:00:00 GMT

Serialization Data - Who Needs It And Why?

For some organizational roles, access to serialization data will be needed on a routine basis to perform on-going activities, while for other roles the need may be required as part of an unplanned event, such as a recall, product complaint, or inquiry.
Healthcare & Life Sciences Institute Mon, 12 Dec 2016 00:00:00 GMT

Value-based pricing in pharmaceuticals - hype or hope?

The industry is under the public and political microscope. Can VBP add the value that healthcare systems and patients are looking for?
Healthcare & Life Sciences Institute Fri, 16 Dec 2016 00:00:00 GMT

Five steps to tackling culture: Why the 'soft stuff' is just as important as the 'hard stuff'

The importance of culture and values is not a new phenomenon. For many years, researchers have pegged culture as the culprit for corporate scandals, failures and industrial disasters.
Healthcare & Life Sciences Institute Fri, 13 Jan 2017 00:00:00 GMT

Key disruptors affecting HCLS - Annual investment summary

Health care is now at an inflection point with key disruptors that will profoundly impact the market and create new opportunities. A better understanding of health care disruptors is imperative to successfully navigating the impending legal/regulatory, economic and technological forces that are...
Healthcare & Life Sciences Institute Tue, 10 Jan 2017 00:00:00 GMT

What Does the Future Hold for the Tax Provisions of the Affordable Care Act?

The structure and design of healthcare reform under the incoming administration of President-Elect Trump is likely to include tax law changes. Although the form of healthcare reform is far from certain, this article speculates as to the path legislation might take and the aspects of current...
Healthcare & Life Sciences Institute Sun, 27 Nov 2016 00:00:00 GMT

Balancing the enterprise

How do healthcare organizations contain costs and risk while improving safety? Depending on your enterprise asset management strategy, the answer might be closer than you think.
Healthcare & Life Sciences Institute Wed, 08 Feb 2017 00:00:00 GMT

Medical Device Cyber Trends: Cybersecurity in the medical device industry

In today's changing medical device landscape, with current guidelines and developing regulations, understanding technical requirements impacting the medical device industry is only part of the equation. Similar to other industries, medical devices manufacturers must detect signals of change and...
Healthcare & Life Sciences Institute Tue, 31 Jan 2017 00:00:00 GMT

The real risk in life sciences - Neglecting to evolve compliance programs

Over the past decade, compliance programs at life sciences companies have grown in scope and complexity. Now, executives and boards of directors are questioning whether these larger programs are effectively reducing their risks, or have they become too onerous to deliver real business value?
Healthcare & Life Sciences Institute Tue, 10 Jan 2017 00:00:00 GMT

Navigating change across the care continuum

As healthcare organizations are under significant pressure to shift from “volume to value,” providers will need to articulate how they are improving clinical outcomes throughout the care continuum at a lower cost.
Healthcare & Life Sciences Institute Wed, 08 Feb 2017 00:00:00 GMT

Pharma outlook 2030: From evolution to revolution

We believe that pharmaceutical revenues will fall well short of forecasts, as current projections, as well as business and operating models, do not reflect the turbulence in the marketplace.
Healthcare & Life Sciences Institute Wed, 08 Feb 2017 00:00:00 GMT

Beyond Implementation: Optimizing EHRs to realize results

Many healthcare providers have not realized the full value of their electronic health record (EHR) systems, prompting them to put more emphasis on optimizing their investments.
Healthcare & Life Sciences Institute Wed, 08 Feb 2017 00:00:00 GMT

HHS Proposed Rule to Stabilize the Marketplaceā€¦ but is it enough?

While Congress continues to deliberate a partial repeal and replace of the Affordable Care Act, the Department of Health & Human Services released a proposed rule to provide continued coverage to millions of Americans in the 2018 plan year and beyond.
Healthcare & Life Sciences Institute Thu, 23 Feb 2017 00:00:00 GMT
76 - 90 of 146 Results: